Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Seaport Therapeutics, Inc (SPTX : NSDQ)

• Company Description    - Number of Employees: 58

• Price / Volume Information    Yesterday's Closing Price: $21.10 Daily Weekly Monthly 20 Day Moving Average: 143,677 shares Shares Outstanding: 53.53 (millions) Market Capitalization: $1,129.50 (millions) Beta: 52 Week High: $23.00 52 Week Low: $14.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 8.99% 8.19% 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 101 Seaport Blvd. Floor 12 - BOSTON,MA 02210 USA ph: 617-807-4062 fax: - ir@seaporttx.com http://www.seaporttx.com

• General Corporate Information    Officers Daphne Zohar - Chief Executive Officer Steven M. Paul - Chairman Lauren A. White - Chief Financial Officer Robert J. Hombach - Director Sharon Mates - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 81221K108 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 09/14/26 Share - Related Items Shares Outstanding: 53.53 Most Recent Split Date: (:1) Beta: Market Capitalization: $1,129.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.60 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-3.62 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/14/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - - 03/31/26 - 13.24 12/31/25 - 17.46 Quick Ratio 06/30/26 - - 03/31/26 - 13.24 12/31/25 - 17.46 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - - 12/31/25 - - Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©